What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

High levels of inflammatory biomarkers are associated with a higher incidence of acute heart failure (HF), increased risk of readmission, and higher mortality. 1 There is also a strong correlation ...

Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...

An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...

Sleep apnea is prevalent in patients with HF, adding a high-risk comorbidity that can persist even after heart transplant, say the authors of a new study. The findings highlight the important role ...

Key opinion leaders hold a discussion highlighting significant factors in heart failure staging. This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved outcomes and symptoms in patients with moderate to severe mitral ...

Alexandria Nyembwe is a registered nurse and health writer. She has worked in street medicine serving populations experiencing homelessness in Skid Row Los Angeles as well as in cardiovascular care in ...

For decades, Linda Lopes, 77, lived an energetic lifestyle, having spent 40 years of her life working on her family’s dairy farm. “I was pretty active, doing things like mowing my own lawn and ...